← Back to Search

Cendakimab for Healthy Subjects

Phase 1
Waitlist Available
Research Sponsored by Bristol-Myers Squibb
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to day 107
Awards & highlights

Study Summary

This trial will study how much of the drug cendakimab gets into people's bodies when given under the skin, in healthy volunteers.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to day 107
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to day 107 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
AUC from time zero extrapolated to infinite time (AUC(INF))
Area under the concentration-time curve (AUC) from time zero to time of last quantifiable concentration (AUC(0-T))
Maximum observed concentration (Cmax)
Secondary outcome measures
Apparent total body clearance (CL/F)
Number of Participants with Adverse Events (AEs)
Number of participants with clinical laboratory abnormalities
+8 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Part 2Experimental Treatment1 Intervention
Group II: Part 1Experimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cendakimab
2022
Completed Phase 1
~130

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Bristol-Myers SquibbLead Sponsor
2,638 Previous Clinical Trials
4,128,410 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are included in the current study?

"Affirmative. The information hosted on clinicaltrials.gov illustrates that this research initiative, which was inaugurated on May 2nd 2022, is actively recruiting participants. Specifically, 104 patients must be enrolled from two distinct medical centres."

Answered by AI

Is the eligibility criteria for this research project restricted to those under 50 years old?

"This clinical trial stipulates a patient must be between 18 and 55 years old to meet the enrollment requirements."

Answered by AI

Are there any adverse effects associated with Cendakimab treatment?

"As this trial is in the early stages of testing, only preliminary data supports Cendakimab's safety and effectiveness. Therefore, our team at Power has assigned a score of 1 to it."

Answered by AI

Is there still capacity for new participants in this research endeavor?

"According to the records on clinicaltrials.gov, this investigation is currently enrolling participants; it was first listed on May 2nd 2022 and its information has been refreshed as recently as September 22nd 2022."

Answered by AI

Is participation in this trial open to me?

"This clinical trial is actively seeking 104 healthy individuals between 18 and 55 years old. To be accepted, potential participants must satisfy the desired health criteria."

Answered by AI

Who else is applying?

What state do they live in?
California
How old are they?
18 - 65
What site did they apply to?
Local Institution
Anaheim Clinical Trials Llc
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0
Recent research and studies
clinicaltrials.govStudy
A Study to Evaluate the Drug Levels of Cendakimab Delivered Subcutaneously in Healthy Participants
2022. "A Study to Evaluate the Drug Levels of Cendakimab Delivered Subcutaneously in Healthy Participants". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05337345.
~36 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top